Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced ...
Capstan Medical Inc. closed an oversubscribed series C fundraising round that brought in $110 million for the structural heart-focused company. Capstan aims to combine valve implants, advanced ...
"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.